News

The title of the publication is "Encapsulated Cells Expressing a Chemotherapeutic Activating Enzyme Allow the Targeting of Subtoxic Chemotherapy and Are Safe and Efficacious: Data from Two Clinical

The patent covers a wide range of liquid formulations for the prevention and treatment of mucosal diseases and disorders. "Following our recent European licensing agreement with Norgine, the

The study will focus on a medical syndrome, which according to a mounting tide of scientific research is having a debilitating effect on the health and vitality of

The issued patent claims cover systems for determining the activation state of more than one protein in a cell, where the system can utilize any detector, including cytometers

According to the company, the two patents (patent numbers are 8,771,732 and 8,765,175) will be Orange Book-listable. The two patents complement two additional issued formulation patents, as well

As part of the deal, Ligand will be receiving an up-front payment and is also eligible to get revenue from Captisol material sales, potential milestone payments and royalties

The US FDA has also granted priority review status for the BLA with an expected Prescription Drug User Fee Act (PDUFA) action date of 14 February 2015. Pfizer

The acquisition further strengthens Miltenyi Biotec’s portfolio in cell and gene therapy. Assets obtained in the transaction include a broad range of intellectual property, process technologies, and cGMP-qualified

The parallel-group, single-dose study met the criteria for clinical PK similarity on all three required, prospectively defined, PK endpoints: maximum serum concentration (Cmax), area under the time-concentration curve